Maravai LifeSciences Holdings, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corporation |
$3.27 | $603.89 M | -7.27 | 73 | $18.14 M |
AGIO
Agios Pharmaceuticals, Inc. |
$33.54 | $2.70 B | -7.55 | 486 | $36.50 M |
AKRO
Akero Therapeutics, Inc. |
$27.64 | $1.59 B | -7.1 | 63 | $0 |
ALEC
Alector, Inc. |
$2.02 | $420.24 M | -3.14 | 238 | $100.56 M |
APLS
Apellis Pharmaceuticals, Inc. |
$34.38 | $4.90 B | -11.77 | 705 | $709.95 M |
ARGX
argenx SE |
$645.37 | $22.33 B | -66.05 | 1148 | $1.23 B |
ARQT
Arcutis Biotherapeutics, Inc. |
$14.71 | $838.13 M | -2.59 | 342 | $196.54 M |
ASND
Ascendis Pharma A/S |
$140.28 | $7.77 B | -14.19 | 1017 | $363.64 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
CYTK
Cytokinetics, Incorporated |
$49.19 | $6.05 B | -9.78 | 498 | $18.47 M |
DNLI
Denali Therapeutics Inc. |
$19.82 | $2.96 B | -22.1 | 422 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
FOLD
Amicus Therapeutics, Inc. |
$9.30 | $2.98 B | -20.51 | 499 | $528.30 M |
HALO
Halozyme Therapeutics, Inc. |
$50.51 | $6.47 B | 21.1 | 350 | $1.02 B |
HRMY
Harmony Biosciences Holdings, Inc. |
$34.50 | $1.73 B | 13.15 | 268 | $714.73 M |
IMVT
Immunovant, Inc. |
$24.63 | $3.68 B | -13.39 | 207 | $0 |
INCY
Incyte Corporation |
$71.91 | $13.30 B | 17.93 | 2617 | $4.24 B |
INSM
Insmed Incorporated |
$66.62 | $9.17 B | -10.87 | 1271 | $363.71 M |
KRYS
Krystal Biotech, Inc. |
$155.81 | $4.70 B | 75.42 | 275 | $290.52 M |
LEGN
Legend Biotech Corporation |
$34.72 | $8.31 B | -17.66 | 2500 | $627.24 M |
PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
RARE
Ultragenyx Pharmaceutical Inc. |
$42.66 | $3.44 B | -5.21 | 1294 | $560.23 M |
ROIV
Roivant Sciences Ltd. |
$11.51 | $7.73 B | 2 | 908 | $124.80 M |
RXDX
Prometheus Biosciences, Inc. |
$199.92 | $9.56 B | -56.47 | 97 | $6.81 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
